The Korea Drug Development Research Association (KDRA) represents domestic R&D-focused bio healthcare companies and operates the KDRA Bio Healthcare Talent Development Center to cultivate and nurture professionals who can lead the development of the pharmaceutical and bio healthcare industry in alignment with global standards.
As part of this initiative, KDRA hosts specialized training programs across various fields including R&D/IP strategy, domestic and international regulatory affairs, clinical development strategy, and R&D planning/commercialization.
BXPLANT is proud to announce that Co-CEO Heesun Kim and Executive Director Jeonghyun Yu will serve as instructors for the upcoming Drug Product Development Strategy Program. This engagement demonstrates BXPLANT’s commitment to advancing industry expertise and contributing to the professional development of Korea’s bio healthcare workforce.
Through this program, participants will gain insights into strategic approaches to drug development, regulatory considerations, and best practices drawn from BXPLANT’s extensive experience in clinical development and research organization services.
Please refer to the poster above for detailed program information.
All sessions will be conducted in Korean only.
